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Abstract
Gliomas are morbid brain tumors that are extremely resistant to available chemotherapy and radiology treatments. Some
studies have suggested that calcium-activated potassium channels contribute to the high proliferative potential of tumor
cells, including gliomas. However, other publications demonstrated no role for these channels or even assigned them
antitumorogenic properties. In this work we characterized the expression and functional contribution to proliferation of
Ca
2+-activated K
+ channels in human glioblastoma cells. Quantitative RT-PCR detected transcripts for the big conductance
(BK), intermediate conductance (IK1), and small conductance (SK2) K
+ channels in two glioblastoma-derived cell lines and a
surgical sample of glioblastoma multiforme. Functional expression of BK and IK1 in U251 and U87 glioma cell lines and
primary glioma cultures was verified using whole-cell electrophysiological recordings. Inhibitors of BK (paxilline and
penitrem A) and IK1 channels (clotrimazole and TRAM-34) reduced U251 and U87 proliferation in an additive fashion, while
the selective blocker of SK channels UCL1848 had no effect. However, the antiproliferative properties of BK and IK1
inhibitors were seen at concentrations that were higher than those necessary to inhibit channel activity. To verify specificity
of pharmacological agents, we downregulated BK and IK1 channels in U251 cells using gene-specific siRNAs. Although
siRNA knockdowns caused strong reductions in the BK and IK1 current densities, neither single nor double gene silencing
significantly affected rates of proliferation. Taken together, these results suggest that Ca
2+-activated K
+ channels do not play
a critical role in proliferation of glioma cells and that the effects of pharmacological inhibitors occur through their off-target
actions.
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Introduction
Gliomas are primary brain tumors that arise from glial cells.
They represent 30 to 60% of CNS primary tumors, with the
incidence of 2 to 3 new cases per 100,000 persons annually [1,2].
Based on their histopathological characteristics, gliomas are
classified as grades I through IV, with higher grades being more
de-differentiated and malignant [3,2]. Grade IV gliomas, also
known as glioblastoma multiforme (GBM), have a very high
proliferative potential, are invasive and resistant to currently
available therapies [3,4]. Only 30% of GBM patients survive one
year, and the average life expectancy remains approximately 14–
18 months even with maximal therapy including gross total
surgical resection followed by chemotherapy and radiation therapy
[5,6]. Despite medical advances over the past 30 years, there has
not been a significant impact on GBM patient survival [4].
Therefore, a better understanding GBM biology is needed in order
to develop novel therapeutic treatments for this disease.
There is extensive literature suggesting that proliferation of
normal and transformed animal cells requires activity of certain
potassium (K
+) channels (see for example [7,8,9,10]). K
+ channels
are thought to facilitate progression through cell cycle checkpoints,
likely via modulation of membrane potential (reviewed in [11,12]).
Particularly, progression through the G1/S checkpoint in many
cell types is associated with increased K
+ channel activity and
transient hyperpolarization [12]. Conversely, G2/M transition
may involve depolarization and be associated with increased Cl
2
currents [12]. On the other hand, a number of studies suggest that
concomitant modulation of K
+ and Cl
2 channel activity may lead
to cell cycle-dependent changes in cell volume (reviewed in
[13,14]).
One group of K
+ channels that may be relevant to proliferation
of both malignant and non-malignant cells are the Ca
2+-activated
K
+ channels ([14], see also references below). These channels are
subdivided into big conductance (large or maxi-) K
+ channels
(BK), intermediate conductance K
+ channels (IK1), and small
conductance K
+ channels (SK) [15]. Each of these sub-classes can
be discriminated based on their biophysical and pharmacological
properties. BK channels, also known as SLO1, are broadly
expressed in various tissues but have particular functional
PLoS ONE | www.plosone.org 1 August 2010 | Volume 5 | Issue 8 | e12304significance for membrane potential regulation in excitable and
exocrine cells [15,16]. The pore-forming subunit of BK is encoded
by the KCNMA1 gene. BKs are voltage-gated channels that are
activated at high positive potentials with a large unitary
conductance of 100–300 pS. Increases in the intracellular Ca
2+
concentration to the micromolar levels strongly shift the voltage-
dependence of BK to more negative potentials [16]. Paxilline,
penitrem A, iberiotoxin, and low concentrations of tetraethyl
ammonium are potent and specific inhibitors of BK [16]. IK1
channels, also known as KCa 3.1 or SK4, are the product of the
KCNN4 gene. They are expressed in a variety of tissues and play
diverse physiological roles [15,17]. Unlike BK, IK1 channels are
strictly Ca
2+ dependent as their channel-forming subunit is
constitutively associated with calmodulin [18]. Once activated by
cytosolic Ca
2+, they show an intermediate single channel
conductance of 33–42 pS [17]. Clotrimazole and its derivative
TRAM-34 are potent inhibitors of IK1, discriminating it from
other Ca
2+-activated K
+ channels [19,17].
Prior studies have implicated BK channels in the proliferation
and migration of glioblastoma cells [20,21,22]. BK has also been
associated with growth control in cervical, ovarian, prostate, and
breast cancer derived cell lines [23,24,25]. However, a number of
other studies contradict these findings and suggest that BK
channels are not required for proliferation or even have
antitumorogenic properties, including in glioma cells
[26,27,28,29]. In addition to BK, intermediate conductance
Ca
2+-activated K
+ channels (IK1) have also been proposed to
regulate growth rate in numerous types of malignant and non-
malignant mammalian cells [30,31,32,33,34,35]. More important-
ly, the inhibitor of the IK1 clotrimazole strongly reduces tumor
load and metastases in vivo in several cancer types including GBM
[36,37,38]. It should be noted, however, that some studies
question the functional expression of IK1 in GBM cells [22].
Because of the uncertain functional significance of BK and IK
channels in glioblastoma proliferation, in the present study we
used a combination of pharmacological and molecular biology
tools to explore their functional significance. We found that
pharmacological inhibitors of both BK and IK1 strongly suppress
glioma cell growth in an additive fashion. However, low
concentration of the same blockers that were sufficient to inhibit
channel activity had no effect on cell proliferation. To address this
discrepancy, we downregulated BK and IK1 channels using gene-
specific siRNAs. siRNA transfections caused strong reductions in
K
+ current densities but no changes in cell growth. These data
argue against a critical role for BK and IK1 in GBM proliferation.
Materials and Methods
Materials
Clotrimazole, paxilline, penitrem A, 8,14-Diaza-1,7(1,4)-diqui-
nolinacyclotetradecaphane trifluoroacetate salt (UCL1848), and
all other salts and chemicals were from Sigma-Aldrich (St. Louis,
MO, USA) unless otherwise noted. 1-[(2-Chlorophenyl)diphenyl-
methyl]-1H-pyrazole (TRAM-34) was purchased from Tocris
Biosciences (Ellisville, MO, USA). Stock solutions of paxilline
(20 mM), penitrem A (20 mM), clotrimazole (30 mM), and
TRAM-34 (30 mM) were prepared in DMSO and stored at
230uC. UCL1848 was diluted in water at 20 mM.
Cell cultures
Two established astrocytoma/glioblastoma cell lines, U251 MG
and U87 MG, were used in this study. U251 cells were a gift of Dr.
M.G. Kaplitt (Weill-Cornell Medical Center, New York, USA);
their exact passage is unknown. U87 cells were obtained from the
American Type Culture Collection (ATCC, Manassas, VA, USA)
and used at passages 78–90. Both U251 and U87 cells were grown
in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented
with 10% fetal bovine serum (FBS), 50 U/ml penicillin, and
50 mg/ml streptomycin at 37uC in a humidified atmosphere
containing 95% air and 5% CO2. All cell culture reagents are
from Invitrogen-Gibco (Carlsbad, CA, USA). Culture media was
changed twice a week and cells were passaged using recombinant
protease TrypLE when 90–95% confluency was reached.
Primary glioblastoma cells were prepared from a surgical
sample of glioblastoma multiforme. Tissue sample was obtained
with written consent under a protocol approved by Albany
Medical Center Institutional Review Board. Tumor tissue (,200–
300 mg) was washed twice with ice-cold Ca
2+-, Mg
2+-free
phosphate-buffered saline (PBS, pH 7.4), minced to small pieces
and treated with solution of 0.125% Trypsin/0.015% EDTA in
PBS containing 250 mg/ml DNAse I. After brief digestion, tissue
fragments were triturated using fire-polished glass Pasteur pipette,
and the resulting cell suspension was filtered through a Nylon cell
strainer (70 mm, BD Falcon, Bedford, MA, USA). Cell were grown
in T75 cell culture flasks in DMEM plus 20% FBS supplemented
with 100 U/ml penicillin, and 100 mg/ml streptomycin at 37uC
in a humidified atmosphere containing 95% air and 5% CO2.
Analysis of gene expression in tumor samples and
cultured cells
Expression of various Ca
2+-activated K
+ channels in cultured
cells and the surgical GBM tissue sample was analyzed using
quantitative RT-PCR. Cellular or tissue mRNA was isolated using
the RNAqueous-4PCR kit (Applied Biosystems-Ambion, Austin,
Texas, USA) according to the manufacturer’s instructions.
Cultured cells were grown in a 60-mm dish to 60–80% confluency
and lyzed in 700 ml of lysis buffer. The GBM tumor sample
(,100–150 mg) was homogenized in 1 ml lysis buffer provided
with the RNAqueous-4PCR kit. Concentration of mRNA in
resulting samples was quantified using NanoDrop 1000 (Thermo-
Fisher Scientific, Wilmington, DE, USA). mRNA was converted to
cDNA using the iScript cDNA Synthesis kit (Bio-Rad Laborato-
ries, Hercules, CA, USA) according to the manufacturer’s
instructions. One mg of mRNA was used in each 20-ml cDNA
synthesis reaction mix.
Gene expression was quantified by a real-time PCR using the
CFX96 Real-Time PCR Detection System (Bio-Rad) and iTaq
SYBR Green Supermix kit (Bio-Rad) according to the manufac-
turer’s instructions. One ml of cDNA product prepared as
described above was used for each qPCR reaction. Gene
expression was analyzed with the gene-specific QuantiTect Primer
Assays (Qiagen, Hilden, Germany; see Table 1 for the list of
primers). Two housekeeping genes, GAPDH and RPL13A, were
used as internal reference.
Western blot analysis
Protein expression of the IK1 channel was assessed by the
Western blot analysis using polyclonal antibody raised against
synthetic peptide corresponding to a region of human IK1
(LYDLQQNLSSSHRALEKQIDTLAGKLDALTELL-
STALGPRQLPEPSQQSK, Sigma-Aldrich; cat.# AV35098).
Whole cell lysates were diluted with a reducing Laemmli buffer.
Proteins were separated on 10% polyacrylamide gel followed by
transfer onto an Immun-Blot PDVF membrane (Bio-Rad). The
membrane was blocked for 1 hr with 5% nonfat milk in Tris-
Phosphate buffer containing 0.05% Tween 20 (TBS-T). It was
further incubated overnight at 4uC with primary antibody (1:500
dilution). After five washes for 5 min with TBS-T, membranes
BK and IK1 Channels in Gliomas
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secondary antibodies (GE Healthcare/Amersham Biosciences,
Piscataway, NJ; 1:10,000 dilution), followed by four TBS-T
washes. The horseradish peroxidase signal was detected and
digitized using a chemiluminescence ECLplus reagent (GE
Healthcare/Amersham Biosciences) and a luminescent image
analyzer LAS-4000 (FujiFilm Medical Systems, Stamford, CT).
Electrophysiology
BK and IK1 currents were recorded employing conventional
whole-cell patch clamp technique [39]. Ion currents were recorded
using an Axopatch-200B amplifier (Molecular Devices, Sunnyvale,
CA, USA). Patch pipettes were prepared from borosilicate glass
(Warner Instruments, Hamden, CT, USA) using a P-97
micropipette puller (Sutter Instruments, Novato, CA, USA).
Pipette resistances were 2.5–4 MOm when filled with a solution
containing (in mM): 135 KCl, 2 MgSO4, 10 HEPES, 2.5 ATP-Na,
0.1 EGTA (pH=7.2, adjusted with KOH). Bath solution
contained (in mM): 140 NaCl, 5 KCl, 3 CaCl2, 1.2 MgSO4,1 0
HEPES, 10 glucose (pH=7.4, adjusted with NaOH). In
experiments to detect IK1 currents, calcium concentration in
pipette solution was increased to 750 nM by adding CaCl2. Free
Ca
2+ levels were calculated using CaBuf software (G. Droogmans,
KU Leuven, Leuven, Belgium). In all experiments series resistance
was ,15 MOm.
BK currents were recorded from a holding potential of
280 mV in response to step pulses of 280 mV to +140 mV in
20 mV increments. BK current development and inhibition was
monitored by applying repetitive (every 3 sec) depolarization
ramps from 2120 mV to +140 mV. Because the pipette solution
is nominally Ca
2+-free, other Ca
2+ activated K
+ channels, such as
IK1 and SK1-3 are silent under these experimental conditions.
IK1 currents were recorded from a holding potential of
280 mV in response to step pulses from 2120 mV to +80 mV
in 20 mV increments. Development and inhibition of the Ca
2+-
dependent IK1 currents were monitored by applying repetitive
(every 3 sec) depolarization ramps from 2120 mV to +80 mV.
Since these conditions also favor activation of BK currents, 2 mM
paxilline was added to bath solution to isolate the IK1 currents.
Cell proliferation assays
Cell proliferation rates were quantified using two approaches:
Coulter counter technique and colorimetric MTT proliferation
assay. U251 and U87 cells were plated in 24-well cell culture plates
(TPP, Trasadingen, Switzerland, Europe) at the density of 10,000
cells per well and were allowed to grow overnight. The next day,
culture media was replaced with serum-containing or serum-free
media including the various pharmacological inhibitors or vehicle
controls. Initial cell density was quantified at this time in a separate
‘‘baseline’’ plate prepared in the same fashion. We used two types
of culture media in pharmacological experiments: serum-contain-
ing (DMEM plus 10% FBS), or serum-free medium prepared
using OptiMEM with B27 supplement (Invitrogen; 1:50 dilution).
To preclude the potential degradation of inhibitors, we replaced
inhibitor-containing media with freshly prepared every 24 hrs.
48 hrs after first application of inhibitors, extracellular media were
removed and cells were processed for proliferation assays.
For MTT assays, cells were briefly washed with basal solution
containing (in mM): 135 NaCl, 3.8 KCl, 1.2 MgSO4, 1.3 CaCl2,
1.2 KH2PO4, 10 HEPES, and 10 glucose (pH=7.4, adjusted with
NaOH). Aliquots of basal solution containing 0.5 mg/ml thiazolyl
blue tetrazolium bromide (MTT, Sigma-Aldrich) were then added
to each well. After 30-min incubation at 37uC MTT solution was
removed, and cells were solubilized in acidified isopropanol to
dissolve newly formed MTT-formazan particles. 250-ml aliquots
from each well were transferred into a 96-well plate. Absorbances
at 562 nm were measured using ELx800 Absorbance microplate
reader (BioTek Instruments, Winooski, VT, USA).
For Coulter counter assays, cells were detached from substrate
using recombinant protease TrypLE and counted using a Z1
Series Coulter Counter (Beckman Coulter, Miami, FL, USA).
siRNA transfections
To downregulate BK and IK1, U251 cells were transfected with
gene-specific siRNAs using a Nucleofector II (Lonza, Cologne,
Germany) and the Amaxa Nucleofection kit T according to the
manufacturer’s protocol. Cells were removed from the substrate
with TrypLE, counted, centrifuged at 300 g for 10 min, and
mixed with nucleofection suspension buffer containing 0.5 mgo f
GFP cDNA (as a control of transfection efficacy) and 1 mM siRNA
of choice. Cells were electroporated using program T-20 and then
plated on either 24-well plates for proliferation assays or glass
coverslips for patch clamp experiments. We used two to three
siRNA constructs per gene that were obtained from Qiagen or
Ambion. Target sequences for each siRNA are listed in Table 2.
As a negative control we used nonsense AllStars negative control
siRNA (Qiagen) or siRNA to an unrelated K
+ channel TREK.
Statistical analysis
All data presented as mean values 6SE. Number of
independent experiments per group is indicated in each figure
legend. Statistical significance was determined by one-way analysis
of variance (ANOVA) and a priori Newman-Keuls test for multiple
comparisons. p,0.05 was accepted as significant. In those
experiments where experimental values were normalized to
controls, statistical difference from controls was calculated with
unpaired Student’s t-test. Origin 6.0 (Origin Labs, Northampton,
MA, USA) and Prism 5 (GraphPad Software, San Diego, CA,
USA) were used for statistical analysis.
Results
Expression of mRNAs encoding the Ca
2+-activated K
+
channels BK, IK1 and SK1-3 in glioma cell lines and in a
surgical sample of glioblastoma multiforme
We initially evaluated the expression of Ca
2+-activated K
+
channels in glioma cell lines at the mRNA level. U251 and U87
are both derived from human gliomas, but demonstrate different
morphological and growth characteristics as well as substantial
Table 1. Quantitative primers for real time PCR.
Gene Sequence Manufacturer
Catalog
number
RPL13A
(housekeeping)
Proprietary Qiagen QT00089915
GAPDH
(housekeeping)
Proprietary Qiagen QT01192646
KCNMA1 (BK1 or
SLO1)
Proprietary Qiagen QT00024157
KCNN1 (SK1) Proprietary Qiagen QT00025375
KCNN2 (SK2) Proprietary Qiagen QT00016611
KCNN3 (SK3) Proprietary Qiagen QT00070966
KCNN4 (IK1) Proprietary Qiagen QT00003780
doi:10.1371/journal.pone.0012304.t001
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cell express wild type p53, while U251 carry its mutated form [40].
We found expression of BK, IK1, and SK2 transcripts in U251
and U87 cells. The levels of transcripts for each of these channels
were quantitatively similar, representing ,0.5–2% of the mRNA
expression levels for the housekeeping gene GAPDH (Fig. 1). SK1
and SK3 expression levels were negligible. In order to determine if
glioma cells in situ have a similar Ca
2+-activated K
+ channel
expression profile, we isolated mRNA from a surgical sample that
was histopathologically identified as a GBM. In the GBM sample,
BK and IK1 mRNA expression levels were comparable to those in
U251 and U87 cells (Fig. 1). However, GBM SK2 transcript levels
were substantially higher than in glioma cell lines. Additionally, we
found the expression of SK1 and SK3 in the surgical sample that
was not present in the glioma cell lines (Fig. 1).
Functional expression of BK and IK1 in glioma cell lines
and in primary GBM cells
Expression of mRNA does not necessarily result in production
of functional plasmalemmal channels. For example, Weaver et al.
found high levels of the IK1 mRNA but no IK1 immunoreactive
signal in Western blot analysis or functional IK1 currents in
electrophysiological experiments in D54 and U251 glioma cell
lines [22]. Therefore, we assessed the functional expression of
Ca
2+-activated K
+ channels using conventional patch clamp
technique.
When U251 cells were dialyzed with a pipette solution
containing no Ca
2+, we registered large macroscopic K
+ currents
that were activated in response to depolarizing step pulses
.40 mV (Fig. 2A, D). This electrophysiological profile is
characteristic of BK channels [16]. Under these Ca
2+-free
recording conditions, the addition of specific BK channel blockers
paxilline (2 mM, Fig. 2B and C) or penitrem A (1 mM, Fig. 2E and
F) nearly completely suppressed transmembrane K
+ currents.
Paxilline and penitrem A data were corroborated with the BK
peptide inhibitor charybdotoxin (Fig. S1). Average BK current
density, calculated as the paxilline-sensitive component of
macroscopic K
+ currents at +140 mV, was 6769 pA/pF
(n=11). U87 cells also exhibited BK currents of similar amplitude
(data not shown).
To record IK1 currents, we increased [Ca
2+] in the pipette to
750 nM and applied step pulses from –120 mV to +80 mV in
20 mV increments. To prevent concomitant activation of the BK
currents, 2 mM paxilline was included in the bath solution. Under
these recording conditions, we observed macroscopic K
+ currents
that were saturated at voltages $40 mV, consistent with the
electrophysiological profile of IK1 channels (Fig. 2A and C) [35].
The specific blockers of IK1 channels 2 mM clotrimazole (Fig. 2B
and C), and 1 mM TRAM-34 (Fig. 3E and F) inhibited the K
+
currents, indicating that they are indeed mediated by the IK1
channels. In U251 cells, average IK1 current density, calculated as
the clotrimazole-sensitive component, was 2566 pA/pF at 0 mV
(n=6). Similar IK1 currents were recorded in U87 cells (Fig. S2).
Since immortalized cell lines frequently have different gene
expression profile from cells in situ and primary cell cultures, we
performed recordings in primary glioma cultures prepared from a
human surgical sample of GBM. As shown in Fig. 4, primary
GBM cells also exhibited large paxilline-sensitive BK currents
under Ca
2+-free conditions (Fig. 4A–C). Five out of five recorded
cells had BK currents, with average current density 80633 pA/pF
at +140 mV. We also observed the clotrimazole-sensitive IK1
currents when [Ca
2+]i was clamped at 750 nM and 2 mM paxilline
was added to the bath solution (Fig. 4D–F). Three out of six
recorded GBM cells showed IK1 currents with an average current
density of 1366 pA/pF at 0 mV. The reasons for heterogeneity of
IK1 current expression are not clear. However, when observed,
GBM IK1 current densities were not statistically different from
those found in U251 cells.
Our finding of the functional IK1 currents in all glial cell lines
was in conflict with the previous observations of Weaver et al. [22].
Table 2. Gene-specific siRNA constructs used in the gene downregulation experiments.
Target gene siRNA # Sense strand Antisense strand Manuf.
Hs_KCNMA1 BK#15 9-CCUGAAAUCAUAGAGUUAAtt-39 59-UUAACUCUAUGAUUUCAGGga-39 Ambion
Hs_KCNMA1 BK#25 9-CAUCAAUCUAUGCAGUUUtt-39 59-AAACUGCAUAGAUUUGAUGtt-39 Ambion
Hs_KCNN4 IK1#55 9-CUUUGUAAUAAAUGUUAAATT-39 5-UUUAACAUUUAUUACAAAGAT-39 Qiagen
Hs_KCNN4 IK1#65 9-CAUCGGCGCUCUCAAUCAATT-39 59-UUGAUUGAGAGCGCCGAUGCT-39 Qiagen
Hs_KCNN4 IK1#75 9-CCGGAAGCUCCGGGAACAATT-39 59-UUGUUCCCGGAGCUUCCGGTG-39 Qiagen
Hs_KCNK2 TREK1#15 9-CGCAUCAUCUCAACAAUCAtt-39 59-UGAUUGUUGAGAUGAUGCGaa-39 Ambion
N/A NC Proprietary nonsense siRNA (AllStars Negative Control) Qiagen
N/A, not applicable; NC, negative control; Manuf., manufacturer.
doi:10.1371/journal.pone.0012304.t002
Figure 1. mRNA expression of Ca
2+-activated K
+ channels in
human gliomas cell lines and in tissue sample of glioblastoma
multiforme. Relative levels of mRNA expression for BK, IK1 and SK1-3
channels were quantified in U251, U87, and a GBM tissue sample using
reverse transcription quantitative PCR. Expression levels were normal-
ized to the expression of two housekeeping genes, GAPDH (shown in
graph) and ribosomal protein RPL13A. Mean values 6SE of gene
expression in three independent cell preparations for U251 and U81,
and three independent measurements for GBM are shown.
doi:10.1371/journal.pone.0012304.g001
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IK1 protein expression in U251, U87 and GBM cells. Using
commercially available polyclonal IK1 antibody, we identified a
weak immunopositive band of ,46–48 kDa in protein lysates
prepared from all three cell types (Fig. S3). This molecular weight
is very close to the predicted molecular weight of the IK1 protein
(45 kDa).
Effects of BK and IK1 channel blockers on proliferation of
U251 and U87 cells
To explore functional involvement of BK and IK1 channels in
proliferation, we tested the effects of pharmacological inhibitors of
BK and IK1 using two different techniques, Coulter counter and
MTT proliferation assays. Using two alternative approaches was
important because MTT conversion into light-absorbing forma-
zan is mediated by mitochondrial dehydrogenases and may be
affected without changes in cell numbers or viability [42]. In the
FBS-containing media, the BK inhibitor paxilline (10 mM) had no
effect on cell growth, while the IK1 blocker clotrimazole (10 mM)
moderately suppressed cell proliferation of U251 (Fig. 5). The
combination of these two drugs caused a significant reduction of
cell proliferation as measured by both MTT and Coulter counter
assays (Fig. 5 and Fig. S4A). To test whether serum components
may reduce the inhibitory effects of channel blockers, we
performed additional proliferation assays under serum-free
conditions. In OptiMEM medium supplemented with serum
substitute B27, U251 proliferation rates were similar to those in
cells cultured in DMEM plus 10% FBS. In both media we
observed approximately six-fold increases in cell numbers over
48 hrs (data of Coulter counter assays). Under serum-free
conditions the efficacy of paxilline was dramatically increased
(Fig. 5 and Fig. S4B). Furthermore, the combination of paxilline
and clotrimazole produced strong and additive inhibition of cell
growth, reducing it by approximately 70% (Fig. 5, Fig. S4B). The
combination of drugs also induced strong changes in cell
morphology (see Fig. 6A–D). Qualitatively similar data were
obtained in U87 cells, although the latter cells were less sensitive to
the actions of clotrimazole (see Fig. S5 and micrographs in Fig. 6E–
H). To test if drug bio-availability was reduced by the major serum
component albumin, we supplemented serum-free media (Opti-
MEM+B27) with 2 mg/ml bovine serum albumin. Addition of
albumin reverted the inhibitory properties of paxilline and
clotrimazole to the levels seen in serum-containing media,
rendering paxilline completely ineffective (Fig. 5).
We next tested the dose dependency of the effects of paxilline
and clotrimazole on U251 cell proliferation and compared their
efficacy to the specific BK inhibitor penitrem A [43] and the
selective IK1 blocker TRAM-34 [19]. Since high levels of SK2
message were found in both immortalized cell lines and primary
cells, we also tested UCL1848, an inhibitor of SK1, SK2, and SK3
[44]. The BK blockers, paxilline and penitrem A, inhibited U251
proliferation in a dose dependent fashion (Fig. 7). At the highest
tested concentration (30 mM), both agents were cytotoxic, i.e.
reduced cell numbers below seeding densities (Fig. 7A). The IC50
values for both inhibitors were substantially higher than those
reported for inhibition of BK currents. In our hands, paxilline
blocked cell proliferation by 50% at ,13 mM (Fig. 7A), whereas
the reported IC50 for inhibition of the whole-cell currents is
Figure 2. BK channels are functionally expressed in U251 glioma cells. (A) Representative recordings of the whole-cell BK currents elicited
by depolarization step pulses from 280 mV to +140 mV in 20 mV intervals. To prevent concomitant activation of IK1 and SK channels, no Ca
2+ was
added into pipette solution. (B) In the same cell shown in (A), whole-cell K
+ currents were potently suppressed by the specific inhibitor of BK
channels paxilline (2 mM). (C) Whole cell BK currents in response to depolarization ramps from 280 mV to +140 mV. Representative traces in the
absence or presence of paxilline are shown. (D–F) Results of similar experiments employing another selective BK blocker penitrem A (1 mM).
doi:10.1371/journal.pone.0012304.g002
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inhibited proliferation with the IC50 of ,3.5 mM (Fig. 7A), but this
value greatly exceeded ,10 nM concentration required for half-
maximal inhibition of the BK activity [45]. The IK1 inhibitors
clotrimazole and TRAM-34 reduced cell proliferation by 50% at
the concentrations of ,6 and 14 mM, respectively (Fig. 7B). These
values were drastically higher than the IC50 of 70 nM (clotrima-
zole) and 20 nM (TRAM-34) that were obtained in electrophys-
iological experiments [19]. The specific blocker of the SK1-3
channels UCL1848 showed no effect on U251 cell proliferation
(Fig. 7C).
The disparity between the IC50 values for inhibition of
proliferation and channel activity may be explained by decompo-
sition of tested compounds in culture media, or by nonspecific
absorption of the drugs during long incubation. To address this
possibility, we tested the inhibitory properties of culture media
containing nominally 10 mM of either paxilline or clotrimazole
after 24-hr incubation in cell proliferation assays. We diluted
aliquots of the inhibitor-containing culture media 10-fold with
electrophysiological bath solution and performed whole-cell patch
recordings. Such dilution was necessary to minimize differences
between cell culture media and bath solution. The final nominal
concentrations of paxilline and clotrimazole were 1 mM. As seen in
Fig. 7D, E, ‘‘aged’’ paxilline and clotrimazole solutions inhibited
BK and IK1 currents by .90% and .70%, respectively. Notably,
at the nominal concentration of 1 mM, neither paxilline nor
clotrimazole affected cell proliferation (compare to the values
indicated by the block arrows in Fig. 7A and B). Thus, the effects
of paxilline and clotrimazole (as well as the other inhibitors) on cell
proliferation are unlikely related to their actions on BK and IK1
activities.
Effects of gene-specific siRNAs on BK and IK1 channel
activity and cell proliferation
We decided to further test the functional involvement of BK
and IK1 in glioma cell proliferation using an alternative approach.
For this purpose, we downregulated BK and IK1 expression using
an siRNA technique. At 48 hrs after transfection, the two BK-
specific siRNAs significantly downregulated BK mRNA expres-
sion levels by 62% and 58% (Fig. 8A, p,0.01). These values likely
underestimate the degree of mRNA downregulation in individual
cells because only 65–80% of the cells were successfully
transfected, as routinely verified by co-transfection with GFP
(see Fig. S6). U251 cells transfected with siRNA targeting the
unrelated K
+ channel TREK-1 (KCNK2) did not affect levels of BK
mRNA expression (n=3, data not shown). The BK siRNA#2 was
used to test for functional suppression of BK channels. As seen in
Fig. 8B, C, the BK siRNA#2 induced a 52% decrease in the BK
current density 72 hrs after transfection (2965 pA/pF for BK
siRNA vs. 6068 pA/pF for negative control siRNA, p=0.002).
While the BK siRNA#2 successfully downregulated the BK
current densities, neither siRNA#2 nor siRNA#1 affected U251
cell proliferation (Fig. 8D, cell counts performed 72 hrs after
transfection).
Figure 3. IK1 channels are functionally expressed in U251 glioma cells. (A) Representative recordings of the whole-cell IK1 currents elicited
by depolarization step pulses from 2120 mV to +80 mV in 20 mV intervals. Whole cell IK1 currents were activated by clamping pipette [Ca
2+]a t
750 nM. To prevent concomitant activation of BK currents, 2 mM paxilline was added into bath solution. (B) In the same cell shown in (A), the whole
cell IK1 currents were inhibited by the potent IK1 blocker clotrimazole (2 mM). (C) Whole cell currents in response to depolarization ramps from
2120 mV to +80 mV in the absence or presence of clotrimazole. (D–F) Results of similar experiments employing the selective IK1 blocker TRAM-34
(1 mM).
doi:10.1371/journal.pone.0012304.g003
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ulated IK1 mRNA levels by 52% and 70% 48 hrs after
transfection, while the third construct proved ineffective (Fig. 8E).
The most effective IK1 siRNA construct (siIK1#7) was further
tested in electrophysiological functional assays. This siRNA
reduced the IK1 current density by 67% 72 hours after
transfection (762 pA/pF for IK siRNA vs. 2164 pA/pF in
negative control transfections, p=0.003). As in the case of BK
downregulation, the IK1 knockdowns had no effect on prolifer-
ation of U251 cells (Fig. 8H).
Because paxilline and clotrimazole reduced cell proliferation in
an additive fashion, we explored the effects of simultaneous BK
and IK1 downregualtion on rate of U251 cell growth. As in the
case of individual channel knockdowns, a combination of the BK
siRNA#2 and the IK1 siRNA#7 (two constructs that effectively
suppressed BK and IK1 current densities) was ineffective in
inhibiting cell growth (Fig. S7).
Discussion
The main finding of this study is the lack of functional
involvement of the Ca
2+-activated K
+ channels in proliferation of
U251 and U87 glioma cell lines and primary GBM cells. This
conclusion is at odds with some previous reports that also used
pharmacological agents to assay for functional contribution of BK
and/or IK1 to proliferation. Although all the inhibitors of BK and
IK1 that we tested in this study suppressed glioma cell
proliferation, their effects occurred at concentrations significantly
Figure 4. Functional expression of BK and IK1 channels in primary cells derived from glioblastoma multiforme (GBM). (A)
Representative recordings of macroscopic BK currents in primary cells cultured from surgical sample of glioblastoma multiforme. Currents were
elicited by step pulses from 280 mV to +140 mV. (B) In the same cell shown in (A), the BK blocker paxilline (2 mM) potently inhibited macroscopic K
+
currents. (C) Representative traces of K
+ currents elicited in response to depolarization ramps from 280 mV to +140 mV in the absence and presence
of paxilline. (D) Representative recordings of the whole-cell IK1 currents activated by step pulses from 2120 to +60 mV. To isolate IK1 currents,
[Ca
2+]pipette was clamped at 750 nM and 2 mM paxilline was added into bath solution. (E) The specific IK1 inhibitor clotrimazole (2 mM) potently
suppressed macroscopic K
+ currents. (F) Representative traces of K
+ currents elicited in response to depolarization ramps 2120 mV to +60 mV in the
absence and presence of clotrimazole. For additional experimental details, see legend to Fig. 2 and Results section.
doi:10.1371/journal.pone.0012304.g004
Figure 5. Effects of the BK blocker paxilline and the IK blocker
clotrimazole on U251 cell proliferation in serum-containing
and serum-free media. Paxilline (10 mM) and clotrimazole (10 mM)
were added to culture media alone or in combination, and rates of cell
proliferation were determined 48 hrs later using an MTT proliferation
assay. Proliferation assays were performed in standard cell culture
medium (DMEM +10% FBS), serum-free OptiMEM medium supplement-
ed with serum substitute B27, or in OptiMEM+B27 additionally
containing bovine serum albumin (2 mg/ml). Quantitatively similar
data were obtained using Coulter counter assay (see Fig. S2). *, p,0.05,
**p,0.01, ***p,0.001 vs. control;
##p,0.01, combination of drugs vs.
paxilline or clotrimazole alone.
doi:10.1371/journal.pone.0012304.g005
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tion of BK and IK1 activity using siRNA did not cause changes in
cell growth. Therefore, the antiproliferative properties of the BK
and IK1 channel blockers are likely mediated by off target actions.
BK channels are highly expressed in glioma cell lines and in
human glioma tissue [46,47,48,22]. The BK channel expression
correlates with glioma malignancy, with higher levels of the BK
protein seen in more malignant glioma biopsy samples [48]. BK
channels have been implicated in regulation of cell proliferation in
a number of malignant cell lines, such as HeLa and A2780
carcinomas, MCF-7 breast cancer, PC-3 prostate cancer, as well as
in 1321N1 and D54-MG human glioma lines [20,21,23,24,25].
These proliferation studies relied on pharmacological inhibitors of
BK, such as TEA and iberiotoxin. However, more recent
publications, that employed molecular biology techniques and/
or BK channel openers, put forward the opposite idea that BK
channels may have antiproliferative and antitumorogenic proper-
ties. For example, Cambien et al. [29] found that silencing of BK
channels in human osteosarcoma cells strongly increases tumor
load in vivo. In A2780 ovarian cancer cells, the BK opener NS1619
produced potent inhibition of cell proliferation [28]. Our own
results strongly suggest that BK channels do not play a role in
growth of glioma cells in vitro. While the BK blockers paxilline and
penitrem A inhibited proliferation of U251 cells in a dose-
dependent manner, their inhibitory effects were seen at concen-
trations greatly exceeding those necessary for complete channel
block. This points to possible off-target effects of pharmacological
agents. Such conclusion was supported by the results of siRNA
experiments, in which downregulation of BK channel expression
had no impact on U251 proliferation rates. The discrepancy
between our BK data and several other reports in glioma cell lines
may be explained by different conditions employed in cell
proliferation assays. Positive results implicating BK in control of
glioma cell growth have been collected using specific cell growth
conditions, such as elevated extracellular [K
+] [20] or serum
deprivation [21]. In other malignant cell types, the effects of BK
blockers could be seen only when cell growth was stimulated with
certain factors such as estradiol [25,24]. Hence, even if BK may
contribute to cell proliferation under specific conditions, its activity
is not a prerequisite for cell cycle progression in glioma cells.
A somewhat surprising finding of our work was the detection of
functional IK1 channels in two established glioma lines, U251and
U87, as well as in primary GBM cells. Although IK1 mRNA is
consistently detected in immortalized glioma cell lines and human
GBM samples, Weaver et al. found no evidence for the IK1 protein
expression in numerous glioma samples and were unable to detect
whole-cell IK1 currents in U251 cells [22]. Nevertheless, Fioretti et
al. recently reported functional expression of the IK1 channels in
GL-15 and U251 lines and in primary GBM cells [49,50,51],
similar to findings in the present work. The disparity between
these findings and the results of Weaver et al. may be due to
differences in conditions employed in electrophysiological exper-
iments. In order to isolate the IK1 currents, we and Fioretti et al.
suppressed the concomitant BK currents by adding BK blockers
into bath solutions. Furthermore, we recorded IK1 currents with
ATP present in the pipette solution, which may strongly enhance
IK1 activity via a PKC- and/or PKA-dependent mechanism
[52,53]. Unlike Weaver et al., we also found weak immunopositive
protein bands at the molecular weight that was very close to the
predicted molecular weight for the IK1 protein. This band was
Figure 6. Representative micrographs of U251 (A-D) and U87 (E-H) cells grown in the presence of BK and IK1 blockers. Cells were
grown in the serum-free OptiMEM media supplemented with serum substitute B27. The BK blocker paxilline (10 mM) and the IK1 inhibitor
clotrimazole (10 mM) were added as indicated. Images of the cells were captured ,48 hrs after addition of channel blockers using Hoffman
modulation contrast optics in Olympus IX71 microscope at 10610 magnification.
doi:10.1371/journal.pone.0012304.g006
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GBM cells. Such difference in Western blots results may be due to
the higher sensitivity of antibody that was used in our study.
The detection of the IK1 subtype of Ca
2+-activated K
+ channels
in glioma cells may be of substantial importance. These channels
have been implicated in tumorogenesis and regulation of cell
proliferation in a number of cell types, including pancreatic and
endometrial cancer cells, non-malignant endothelial and smooth
muscle cells, and bone marrow mesenchymal cells [31,33,54,35].
In in vivo experiments, systemic application of the IK1 inhibitor
clotrimazole was reported to decrease tumor load and prolong
survival in animal models of glioma and melanoma [36,38]. In our
hands, the specific IK1 blockers clotrimazole and TRAM-34
strongly inhibited proliferation of U251 cells. However, as in the
case of BK blockers, their effective concentrations strongly
exceeded those that were necessary for complete inhibition of
the IK1 currents. Moreover, siRNA downregulation of IK1 did
not affect cell proliferation. Recently, Sciaccaluga et al. discovered
a critical role for the IK1 channels in chemotactic motility of
glioblastoma cells [51]. In this latter study, downregulation of IK1
expression using shRNA completely inhibited cell migration in
response to the chemokine ligand CXCL12 in several glioblastoma
cell lines and primary GBM cells, suggesting a possible role of IK1
in glioblastoma invasiveness [51].
Overall, our data provide strong evidence against a requirement
for the Ca
2+-activated K
+ channels BK and IK1 for proliferation of
U251 cells, and likely other glioma cells. Further work is needed to
define the mechanisms responsible for the antiproliferative effects of
pharmacological inhibitors of BK and IK1, such as paxilline,
penitrem A, clotrimazole, and TRAM-34. Our results suggest that
strong caution should be taken when interpreting positive results
obtained with pharmacological ion channel blockers and that such
experiments should be supplementedwith molecular biology studies
targeting expression of proteins of interest.
Figure 7. Blockers of the Ca
2+-activated potassium channels BK and IK1 suppress proliferation of U251 cells in a dose dependent
fashion. (A) Dose response curves for the effects of the BK channel inhibitors, paxilline and penitrem A, on proliferation of U251 cells. Arrow
indicates concentration of paxilline that was used to block K
+ currents in the electrophysiology experiments presented in (D). (B) Dose response
curves for the effects of the IK1 channel inhibitors, clotrimazole and TRAM-34, on proliferation of U251 cells. Arrow indicates concentration of
clotrimazole that was used to block K
+ currents in the electrophysiological experiments presented in (E). (C) Dose response curves for the effects of
the selective SK1-3 channel blocker UCL1848 on proliferation of U251 cells. (D) Effect of the ‘‘aged’’ paxilline on the whole-cell BK currents. Cell
proliferation medium containing 10 mM paxilline was collected after 24-hr incubation in cell proliferation assays, diluted 10-fold with
electrophysiological bath solution, and used for inhibiting BK currents. Nominal concentration of paxilline was 1 mM (indicated by arrow in (A),
to compare proliferation and electrophysiology data). Representative of three experiments. (E) Effect of the ‘‘aged’’ clotrimazole on the whole-cell IK1
currents. Cell proliferation medium containing 10 mM clotrimazole was collected after 24-hr incubation in cell proliferation assays, diluted 10-fold, and
used for inhibiting IK1 currents. Nominal concentration of clotrimazole was 1 mM (indicated by arrow in (B)). Representative of three experiments. (F)
Comparison of normalized effects of the ‘‘aged’’ paxilline and clotrimazole on the whole cell K
+ currents to their effects on cell proliferation. Inhibition
of BK and IK1 currents was calculated as average inhibition of the whole K
+ cell currents at +140 and 0 mV for BK and IK1, respectively.
doi:10.1371/journal.pone.0012304.g007
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Figure S1 The BK blocker charybdotoxin (100 nM) potently
suppresses whole-cell K+ currents in U251 glioma cells. For
methodological details see Methods and legend to Fig. 2 in the
main text.
Found at: doi:10.1371/journal.pone.0012304.s001 (1.34 MB EPS)
Figure S2 U87 glioma cells express typical IK1 currents that
were potently suppressed by the IK1 blocker clotrimazole (2 mM).
For methodological details see Methods and legend to Fig. 3 in the
main text.
Found at: doi:10.1371/journal.pone.0012304.s002 (1.19 MB EPS)
Figure S3 Western blot analysis of the IK1 protein expression in
glioma cell lines and primary glioblastoma cells. Protein lysates
(20 mg/lane) of primary glioblastoma (GBM), U87, and U251 cells
were separated by sodium dodecyl sulfate polyacrylamide gel
electrophoresis, transferred to the PVDF membrane and probed
with polyclonal anti-IK1 antibody as described in Materials and
Methods. Immunopositive signal was detected and digitized using
chemiluminescence ECLplus reagent kit (GE Healthcare/Amer-
sham Biosciences) and luminescent image analyzer LAS-4000
(FujiFilm Medical Systems, Stamford, CT). Bars and numbers on
the left indicate positions of molecular weight standards (MW).
Weak immunopositive band indicated by asterisk was detected at
the molecular weight of ,46–47 kDa that is close to the predicted
molecular weight of the IK1 protein (45 kDa).
Found at: doi:10.1371/journal.pone.0012304.s003 (0.35 MB EPS)
Figure S4 Effects of paxilline and clotrimazole on proliferation
of U251 cells in serum-containing and serum-free media measured
using two alternative cell proliferation assays. (A) Effects of
paxilline (10 mM) and clotrimazole (10 mM), or their combination
on proliferation of U251 in media containing 10% FBS. Cells were
treated with pharmacological inhibitors for 48 hrs and rates of
proliferation were quantitatively assessed using Coulter Counter
(white bars) and MTT (grey bars) assay. Plating cell density is
indicated by dashed line. (B) Effects of paxilline (10 mM) and
Figure 8. Effects BK and IK1 gene silencing on macroscopic K
+ current densities and proliferation rates in U251 glioma cells. (A)
Effect of the BK-specific siRNAs on BK mRNA expression levels. U251 cells were transfected with negative control siRNA (NC) or two different siRNAs
targeting BK (si1-BK, and si2-BK). 48 hrs post transfection, mRNA levels were quantified and normalized to housekeeping genes GAPDH and RPL13A
using reverse transcription qPCR. Data are the mean values 6SE of 3-5 independent transfections. (B) Representative traces of whole-cell BK currents
measured at 72 hrs after transfection with negative control siRNA (NC) or siRNA targeting BK (si2-BK). (C) Average BK current densities in U251 cells
transfected with negative control (NC) or si2-BK siRNAs, as compared to non-transfected cells (WT). BK current density was measured as paxilline-
sensitive K
+ currents at +140 mV. Data are the mean values 6SE from 11-17 cells per group. **p,0.01, vs. negative control and non-transfected cells.
(D) Effect of transfection with negative control (NC) or BK siRNAs (si1-BK, si2-BK) on proliferation of U251 measured 72 hrs post transfection using
Coulter counter assay. Data are the mean values 6SE of 3 independent cell transfections. (E) Effect of the IK1-specific siRNAs on IK1 mRNA expression
levels. mRNA levels were quantified and normalized to housekeeping genes GAPDH and RPL13A 48 hrs after transfection with negative control siRNA
(NC), and three different siRNAs targeting IK1 (si5-IK1, and si6-IK1, si7-IK1. Data are the mean values 6SE in 3 independent transfections. (F)
Representative whole-cell K
+ currents measured 72 hrs after transfection with negative control siRNA (NC) or IK1siRNA (si7-IK1). (G) Average IK1
current densities in cells transfected with negative control (NC) or si7-IK1 siRNAs, as compared to non-transfected cells (WT). IK1 current density was
measured as clotrimazole-sensitive K
+ currents at 0 mV with 2 mM paxilline added to bath solution. Data are the mean values 6SE from 14-15 cells
per experimental group, and n=6 in WT. **p,0.01, vs. negative control and non-transfected cells. (H) Effect of nucleofection with negative control
siRNA (NC), or IK1-siRNA (si5-IK1, si6-IK1, si7-IK1) on cell proliferation measured 72 hrs post nucleofection using MTT assay. Data are the mean values
6SE of 3 independent cell transfections.
doi:10.1371/journal.pone.0012304.g008
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U251 cells in serum-free media supplemented with serum
substitute B27. Cell proliferation was quantified using Coulter
Counter (open bars) or MTT assay (grey bars). (C) Effects of
paxilline (10 mM) and clotrimazole (10 mM) or their combination
on proliferation of U251 cells in serum-free media supplemented
with serum substitute B27 and bovine serum albumin. Prolifera-
tion rates were measured using MTT proliferation assay. Data are
the mean values 6SE of proliferation normalized to controls in the
same experiments. **p,0.01 vs. control; **p,0.05 vs con-
trol;***p,0.001 vs. control.
Found at: doi:10.1371/journal.pone.0012304.s004 (0.41 MB EPS)
Figure S5 Effects of paxilline and clotrimazole on proliferation
of U87 cells in serum-containing and serum-free media. (A) Effects
of paxilline (10 mM) and clotrimazole (10 mM) or their combina-
tion on proliferation of U87 in media containing 10% FBS. Cells
were treated with pharmacological inhibitors for 48 hrs and rates
of proliferation were quantitatively assessed using MTT assay.
Data are the mean values of proliferation 6SE normalized to
controls in the same experiments. (B) Effects of paxilline (10 mM)
and clotrimazole (10 mM) or their combination on proliferation of
U87 cells in serum-free media supplemented with serum substitute
B27. Data are the mean values of proliferation 6SE normalized to
controls in the same experiments. **p,0.01 vs. control;
***p,0.001 vs. control.
Found at: doi:10.1371/journal.pone.0012304.s005 (0.39 MB EPS)
Figure S6 Representative images of U251 cells transfected with
the GFP-expressing plasmid using amaxa nucleofection protocol.
Images of the same field were acquired using Olympus IX71
Hoffman modulation contrast optics (A) and GFP fluorescence (B)
72 hrs after nucleofection at 10610 magnification. Transfection
efficacy varied between 60–90% in various cell preparations.
Found at: doi:10.1371/journal.pone.0012304.s006 (1.24 MB EPS)
Figure S7 Double knockdown of BK and IK1 K+ channels does
not affect proliferation of U251 glioma cells. Effect of transfection
with negative control (NC), BK-specific siRNA #2 (siBK), IK1-
specific siRNA#7 (siIK1) or combination of BK- and IK1-specific
siRNAs (siBK+siIK1) on proliferation of U251 measured 72 hrs
post transfection using MTT proliferation assay. Data are the
mean values 6SE of 3 independent cell transfections.
Found at: doi:10.1371/journal.pone.0012304.s007 (0.32 MB EPS)
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